The United States approved the new operation: the lens implanted in the eye for myopia
release time：2016-07-19 09:51:34 read：879
Many people suffer from high myopia, and they cant even see whats under the nose. Now these people have a new treatment option. The United States Food and Drug Administration officially approved the transplant surgery in September 13th.
The doctor cut a small opening on the lens in front of the eyeball. Surgery costs for each eye between 3000 to 4000 U.S. dollars, and the current market is more common in situ corneal laser surgery (LASIK) is the price of 1785 U.S. dollars per eye.
This lens is manufactured by the United States Af Taco (Ophtec) company. Reichardt Makale, chairman and chief executive officer, said, in general, the lens of the transplant surgery is not within the scope of insurance claims, because this operation is not a must. But he also said that for some patients with severe myopia, the insurance company will provide help for their surgery. Because it can make a person who cant work before re - have the ability to work.
It is estimated that 53% of Americans use glasses or contact lenses to correct vision, so the prospect of this new type of lens is very broad. "The market for this kind of surgery is huge, like the prospect of ten years ago when laser surgery is just as promising," says Robert Maroni, an associate professor at the University of California at Los Angeles." Since 1997, Maroni has been the implementation of a pilot lens transplant for almost 100 patients, he said, the accuracy of this surgery is higher than the laser surgery to 50%.
However, there are still some people believe that this surgery may cause cataracts, or to bring other damage to the eye. Baramyri Emba said the eye cornea expert medical college of Georgia: "although this possibility is very small, but we still can not be ignored. Because after opening the eyes, the bacteria are likely to enter the eye every moment." Vice chairman of the global advanced medical optics clinical research and Development Association Nicholas Tarantino said that in the United States in clinical practice, there is no patient and therefore have a cataract.
The United States Food and drug administration has asked the company to follow up a 5 year follow-up survey of patients who have had a lens transplant to determine if there are other side effects. The food and Drug Administration said a question worth considering is that the lens transplant corneal endothelial cell will decrease after operation. These cells can form a protective layer on the cornea below, to ensure clear cornea. In the test, corneal endothelial cells in each of these people will be reduced by 1.8%.
The doctor cut a small opening on the lens in front of the eyeball. Surgery costs for each eye between 3000 to 4000 U.S. dollars, and the current market is more common in situ corneal laser surgery (LASIK) is the price of 1785 U.S. dollars per eye.
This lens is manufactured by the United States Af Taco (Ophtec) company. Reichardt Makale, chairman and chief executive officer, said, in general, the lens of the transplant surgery is not within the scope of insurance claims, because this operation is not a must. But he also said that for some patients with severe myopia, the insurance company will provide help for their surgery. Because it can make a person who cant work before re - have the ability to work.
It is estimated that 53% of Americans use glasses or contact lenses to correct vision, so the prospect of this new type of lens is very broad. "The market for this kind of surgery is huge, like the prospect of ten years ago when laser surgery is just as promising," says Robert Maroni, an associate professor at the University of California at Los Angeles." Since 1997, Maroni has been the implementation of a pilot lens transplant for almost 100 patients, he said, the accuracy of this surgery is higher than the laser surgery to 50%.
However, there are still some people believe that this surgery may cause cataracts, or to bring other damage to the eye. Baramyri Emba said the eye cornea expert medical college of Georgia: "although this possibility is very small, but we still can not be ignored. Because after opening the eyes, the bacteria are likely to enter the eye every moment." Vice chairman of the global advanced medical optics clinical research and Development Association Nicholas Tarantino said that in the United States in clinical practice, there is no patient and therefore have a cataract.
The United States Food and drug administration has asked the company to follow up a 5 year follow-up survey of patients who have had a lens transplant to determine if there are other side effects. The food and Drug Administration said a question worth considering is that the lens transplant corneal endothelial cell will decrease after operation. These cells can form a protective layer on the cornea below, to ensure clear cornea. In the test, corneal endothelial cells in each of these people will be reduced by 1.8%.